Ozone: a possible cause of hemolytic anemia in glucose-6-phosphate dehydrogenase deficient individuals
Calabrese EJ, Kojola WH, Carnow BW. Journal of Toxicology and Environmental Health, 1977.
- Study type
- Other
- Published
- 1977, Journal of Toxicology and Environmental Health
- Identifiers
- PMID 846014, DOI 10.1080/15287397709529470
What the authors reported
A theoretical model predicting that people with glucose-6-phosphate dehydrogenase (G6PD) deficiency may experience acute hemolysis on exposure to ozone at levels reached in polluted urban air.
What limits this result
A theoretical, computational model of inhaled ambient ozone, not an experiment on blood or on any ozone therapy procedure; does not test the brief controlled blood contact EBO2 or MAH use.
Harms reported after ozone therapy, and studies of how ozone exposure affects health. One study rarely settles a medical question; our guides weigh each paper against the rest of the evidence.
Where we cite this study
Who Should Not Get EBO2 (EBOO)? Contraindications and Precautions
The contraindications, relative precautions, and screening questions clinics commonly use for EBO2 (EBOO), and the reasoning behind each one.
EBO2 (EBOO) Side Effects and Safety: What the Evidence Shows
What clinics and the small EBOO research base report about side effects, the risks that come with any extracorporeal circuit, and what regulators have said.